Clinical Trials · NCT06643728
A Study to Investigate Weight Management With Bimagrumab (LY3985863) and Tirzepatide (LY3298176), Alone or in Combination, in Adults With Obesity or Overweight
- Phase
- Phase 2
- Recruitment status
- Active Not Recruiting
- Sponsor
- Eli Lilly and Company
- Enrollment
- 252
- Start date
- Oct 2024
- Locations
- 12 sites, United States
- Primary endpoint
- Percent Change from Baseline in Body Weight